Jordan Corey

Jordan Corey, CFA, is an experienced finance professional with a robust background in investment management and corporate finance. Currently serving as an Equity Research Analyst and Client Portfolio Manager at Scharf Investments, LLC, a $4 billion investment management firm, Jordan focuses on valuation, margin of safety, and portfolio concentration. Prior to this role, Jordan was the Chief Financial Officer at CERo Therapeutics, Inc., advancing innovative immunotherapy solutions, and held the position of Vice President of Finance and Investor Relations at Vir Biotechnology, Inc., specializing in immunotherapies for infectious diseases. Jordan's earlier experience includes roles at BMGI/Cascade Investment, where expertise in multi-asset class investments was developed, and at American Capital in valuations and portfolio monitoring. Jordan holds an MBA in Finance from the University of California, Berkeley, Haas School of Business, and a BA in Liberal Arts and Sciences from the University of Michigan.